Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Liquid Biopsy Surveillance and Early Detection Summit

Evvnt Promotion / evvnt
-
16.11.2022 - 17.11.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 07:30 - 16:00
 
Temi della conferenza
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1315351-3?pid=4832

Speakers: Aadel Chaudhuri, Assistant Professor of Radiation Oncology, Washington University School of Medicine, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1315351-2?pid=4832
Mr. Alex Domingo
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developers and Academics Conference Pass: USD 0.50, Commercial Vendors Conference Pass: USD 3599.00, Technical Vendors Conference Pass: USD 2599.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk AustriaCharité International AcademyÖsterreichisches Rotes KreuzAlumni Club Medizinische Universität WienHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthÄrztekammer für Wien